# OnCo record gilteritinib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/gilteritinib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "gilteritinib" ;
  schema:name "Gilteritinib"@en ;
  schema:description "A single pill that beats salvage chemotherapy for relapsed FLT3-mutated AML, and the backbone of the triplets now being tested in frontline disease."@en ;
  schema:url <https://onco.cc/drugs/gilteritinib/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Gilteritinib> ;
  owl:sameAs <http://www.wikidata.org/entity/Q27077802> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Gilteritinib> ;
  onco:status "approved" ;
  onco:modality "Small-molecule kinase inhibitor (FLT3, type I)" ;
  schema:alternateName "Xospata" ;
  onco:approval "US 2018: Relapsed or refractory FLT3-mutated AML" ;
  onco:related <https://onco.cc/biomarkers/flt3-itd/>, <https://onco.cc/biomarkers/flt3-tkd/> ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/aml-flt3/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/flt3/> ;
  onco:companies <https://onco.cc/companies/astellas/> ;
  onco:terms <https://onco.cc/terms/differentiation-syndrome/> ;
  onco:trials <https://onco.cc/trials/admiral/>, <https://onco.cc/trials/nct04988555/>, <https://onco.cc/trials/nct05520567/>, <https://onco.cc/trials/nct03182244/> .